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Abstract Williams-Beuren syndrome (WBS) is a neuro-
developmental disorder caused by the hemizygous deletion
of 28 genes on chromosome 7, including the general
transcription factor GTF2IRD1. Mice either hemizygously
(Gtf2ird1
+/−) or homozygously (Gtf2ird1
−/−) deleted for
this transcription factor exhibit low innate anxiety, low
aggression and increased social interaction, a phenotype
that shares similarities to the high sociability and disinhi-
bition seen in individuals with WBS. Here, we investigated
the inhibitory effects of serotonin (5-HT) on the major
output neurons of the prefrontal cortex in Gtf2ird1
−/− mice
and their wildtype (WT) siblings. Prefrontal 5-HT receptors
are known to modulate anxiety-like behaviors, and the
Gtf2ird1
−/− mice have altered 5-HT metabolism in prefron-
tal cortex. Using whole cell recording from layer V neurons
in acute brain slices of prefrontal cortex, we found that 5-
HT elicited significantly larger inhibitory, outward currents
in Gtf2ird1
−/− mice than in WT controls. In both genotypes,
these currents were resistant to action potential blockade
with TTX and were suppressed by the selective 5-HT1A
receptor antagonist WAY-100635, suggesting that they are
mediated directly by 5-HT1A receptors on the recorded
neurons. Control experiments suggest a degree of layer and
receptor specificity in this enhancement since 5-HT1A
receptor-mediated responses in layer II/III pyramidal neurons
were unchanged as were responses mediated by two other
inhibitory receptors in layer V pyramidal neurons. Further-
more, we demonstrate GTF2IRD1 protein expression by
neurons in layer Vof the prefrontal cortex. Our finding that 5-
HT1A-mediated responses are selectively enhanced in layer
V pyramidal neurons of Gtf2ird1
−/− mice gives insight into
the cellular mechanisms that underlie reduced innate anxiety
and increased sociability in these mice, and may be relevant
to the low social anxiety and disinhibition in patients with
WBS and their sensitivity to serotonergic medicines.
Keywords 5-HT1A receptors.Gtf2ird1 transcription
factor.Williams syndrome.Prefrontal cortex.Social
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Metabotropic glutamate receptors 2/3 (mGluR2/3)
Introduction
Williams-Beuren syndrome (WBS) is a neurodevelopmental
disorder characterized by cardiovascular disease, distinctive
facial features, hypersociability, mild to moderate mental
retardation and a unique cognitive profile (Bellugi et al. 2000;
Mervis et al. 2000; Meyer-Lindenberg et al. 2006). WBS is
caused by a common hemizygous deletion of less than 30
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correlations between genes, physiology and social behavior.
The identification of individuals with smaller, overlap-
ping deletions has helped geneticists tease apart the
contribution of specific genes to the WBS phenotype
(Tassabehji et al. 1999; Gagliardi et al. 2003), but since
these individuals are rare, this approach has been
complemented by the generation of transgenic animal
models. Several mouse models have been described in
which genes in the WBS critical region have been deleted
and these have enabled the assessment of the contribution
of individual genes to WBS (Li et al. 1998; Hoogenraad et
al. 2002;M e n ge ta l .2002; Crackower et al. 2003;Y o u n g
et al. 2008;O s b o r n e2010).
One of the most striking features of WBS is that of
altered social behavior. Despite their heightened friend-
liness and interest in other people, individuals with WBS
encounter problems in daily life because of their inability
to interact according to social norms (Gosch and Pankau
1994;D a v i e se ta l .1997; Tager-Flusberg and Sullivan
2000). Until recently, however, no mouse model exhibited
behaviors akin to the low social anxiety and disinhibition
seen in WBS, making it a difficult aspect of the disorder to
study in the laboratory. By running behavioral assays such
as the elevated plus maze, open field and resident intruder
tests, Young et al. (2008) were able to show that mice with
either a reduction or a lack of the general transcription
factor gene Gtf2ird1 exhibit decreased anxiety, enhanced
sociability and reduced aggression. This study also showed
that Gtf2ird1
−/− mice had normal serotonin (5-HT)
levels and significantly elevated 5-hydroxyindoleacetic
acid (5-HIAA) levels in prefrontal cortex (Young et al.
2008).
It has been suggested that dysregulation of prefrontal
output in individuals with WBS accounts for the reduced
social anxiety in this population (Meyer-Lindenberg et al.
2005). The prefrontal cortex plays a key role in anxiety
(Chua et al. 1999; Davidson et al. 1999; Liotti et al. 2000;
Osuch et al. 2000) and its neuromodulation by 5-HT is
important in mediating this function. In particular, imaging
studies in humans indicate that reduced 5-HT1A receptor
binding correlates with trait anxiety both in healthy
volunteers (Tauscher et al. 2001) and in patients afflicted
with social anxiety disorder (Lanzenberger et al. 2007). In
mice, 5-HT1A receptor knockouts exhibit increased anxiety
(Heisler et al. 1998; Parks et al. 1998; Ramboz et al. 1998)
and expression of this receptor in forebrain structures
appears to be sufficient to establish normal anxiety
responses (Gross et al. 2002). In contrast, overexpression
of 5-HT1A receptors leads to decreased anxiety (Kusserow
et al. 2004).
While it is known that Gtf2ird1
−/− mice exhibit low
anxiety, reduced aggression and increased sociability
(Young et al. 2008), it is not known how prefrontal neurons
in these mice respond to 5-HT. Here, we use whole cell
electrophysiology in acute brain slices to examine how the
major output neurons of prefrontal cortex are modulated by
serotonin in Gtf2ird1
−/− mice and their wildtype littermate
controls. Since significant differences emerged on this
measure between the genotypes, we tested the specificity
of these differences for the cortical layer and for the recep-
tors involved. We also investigated the expression of genes
that may affect 5-HT1A receptor function and correlated
the localization of GTF2IRD1 protein with the neuro-
physiological difference found in the Gtf2ird1
−/− mice.
This is the first examination of cellular neurophysiology
in a mouse model of WBS exhibiting a low anxiety
phenotype.
Materials and methods
Gtf2ird1
−/− mice
Gtf2ird1 knockout mice were generated by homologous
recombination as described previously (Young et al. 2008).
The mice were maintained on the same CD1 background as
they were for the previous behavioural analyses (Young et al.
2008) and had reached the N8 generation of backcrossing
at the time of these experiments. For all experiments
Gtf2ird1
−/− mice and wildtype (WT) littermates were gen-
erated through the intercrossing of Gtf2ird1
+/− heterozygous
mice.
Brain slice preparation
Coronal slices (400 µm thick) of the medial prefrontal
cortex were prepared from male, adult Gtf2ird1
−/− mice
and their WT littermates. The brain was cooled as rapidly
as possible with 4°C oxygenated sucrose artificial cere-
brospinal fluid (ACSF) (254 mM sucrose was substituted
for NaCl). Prefrontal slices were cut from anterior to
posterior using the appearance of white matter and the
corpus callosum as anterior and posterior guides. The
slices were cut on a Dosaka Linear Slicer (SciMedia),
and were transferred to 30°C oxygenated ACSF (con-
taining the following, in mM: 126 NaCl, 10 D-glucose,
24 NaHCO3,2C a C l 2,2M g S O 4, 3 KCl, 1.25 NaH2PO4,
pH 7.4) in a prechamber (Automate Scientific) and
allowed to recover for at least 1.5 h before the beginning
of an experiment. For whole recordings, slices were
placed in a modified chamber (Warner Instruments)
mounted on the stage of an Olympus BX50WI micro-
scope. Regular ACSF was bubbled with 95% oxygen and
5% carbon dioxide and flowed over the slice at 30°C with
ar a t eo f3 –4 ml/min.
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Whole-cell patch electrodes (2–3M Ω) contained the
following (in mM): 120 K-gluconate, 5 KCl, 2 MgCl,
4 K-ATP, 0.4 Na2-GTP, 10 Na2-phosphocreatine, and 10
HEPES buffer (adjusted to pH 7.33 with KOH). Layer V
pyramidal neurons were patched under visual control using
infrared differential interference contrast microscopy in the
cingulate and prelimbic regions, as illustrated in the
schematic in Fig. 1a. In voltage-clamp, neurons were held
at −75 mV, near the calculated equilibrium potential for
chloride under these conditions, and currents were recorded
using continuous single electrode voltage-clamp mode with
a Multiclamp 700b (Molecular Devices), acquired and low-
pass filtered at 3 kHz with pClamp10.2/Digidata1440
(Molecular Devices). The reversal potential for K
+ is
−97 mV under these recording conditions. After gaining
access to a cell, membrane potential, spike amplitude and
input resistance were measured in current clamp. Prelimi-
nary concentration response experiments in voltage-clamp
(5-HT; 3 µM–100 µM, 30 s) showed that 5-HT elicited
outwards currents in layer V pyramidal neurons, consistent
with previous work in rats (Béïque et al. 2004). Serotonin
(30 µM), GABAB agonist baclofen (30 µM) and mGluR2/3
agonist APDC (30 µM) all elicited near-maximal responses
that could be replicated with a second application after 5–
7 min of washout. Currents were measured in Clampfit by
subtracting the mean outward current at the peak of the
response from the mean holding current at baseline.
Drugs
t-APDC and baclofen were obtained from Tocris bioscience
(Burlington, ON, Canada), serotonin creatinine sulfate and
WAY-100635 from Sigma-Aldrich (St-Louis, MO, USA)
and TTX from Alomone labs Ltd. (Jerusalem, Israel). All
drugs were bath applied.
Statistical analysis
We analyzed normality, conducted one-way analyses of
variance, and computed means and moments of peak
electrophysiological currents with JMP software (a SAS
software, Cary, NC). Significance level was set at 0.05.
Quantitative RT-PCR
Expression analysis was carried out using total RNA extracted
from dissected adult frontal cortex with TriReagent (Sigma-
Aldrich Canada, Oakville, ON). Following DNase treatment
(Turbo DNA free, Ambion), 5 μg of RNA was converted to
cDNA using the SuperScript™ First-Strand Synthesis System
(Invitrogen Canada Inc., Burlington, ON) and random
hexamer primers. Samples were diluted 1/100 with sterile
water and used directly in real-time assays using the Power
SYBR Green PCR Master mix and ABI Prism 7900HT
sequence detection system (Applied Biosystems, Foster City,
CA) as described previously (Somerville et al. 2005). All
samples were run in triplicate and the experiment was
repeated twice with consistent results. Absolute quantification
analysis, normalized to the expression of the control gene
succinate dehydrogenase (Sdha), was used to determine
expression levels. Pair wise comparison of gene expression
in Gtf2ird1
−/− (n=12) and WT (n=12) mice was performed
using a two-tailed Student’s t-test in PAST (PAlaeontological
STatistics)(http://folk.uio.no/ohammer/past/). Primer sequen-
ces are as follows: 5-ht1aF 5′-CTGGGGACGCTCATT
Fig. 1 Serotonin (5-HT) elicits a larger inhibitory outward current
in prefrontal layer V pyramidal neurons from Gtf2ird1
−/− mice
when compared to recordings from wildtype (WT) mice. a
Schematic of a coronal section of prefrontal cortex. The vertical
bar indicates the region in which whole-cell recordings of layer V
pyramidal neurons were performed. b Representative voltage-clamp
traces show that 5-HT application induces a larger inhibitory
outward current in Gtf2ird1
−/− than WT, as measured at its peak.
Gray bar denotes 5-HT application. c Bar graph of average peak
amplitudes of outward currents. N values are bracketed; error bars
represent the standard error and highlight the variance of the current
distributions (* denotes P<0.05)
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5-ht1bF 5’-GAGTCCGGGTCTCCTGTGTA-3’; 5-ht1bR 5’-
TAGC GGCCATGAGTTTCTTC-3’;5 - h t 2 a F5 ’-TGTGCCG
TCTGGATTTACCT-3’;5 - h t 2 a R5 ’-TGAATGGGGT
TCTGGATAGC-3’;5 - h t 2 c F5 ’-CATGGCAGTAAGCAT
GGAGA-3’ ;5 - h t 2 c R5 ’-AGTCCCACCAGCATATC AG
C-3’; MaoaF 5’-GTGCCTGGTCTGCTCAAGAT-3’ ;
MaoaR 5’-TTCAGGACTGGGGCTGTTTA-3’; SdhaF 5’-
TGATCTTCGCTGGTGTGGATGTCA-3’; SdhaR 5’-CCC
ACCCATGTTGTAATGCACAGT-.
Generation of Gtf2ird1
(XS0608)Wtsi mice
Clone XS0608 (embryonic stem cells 129SvEv) carrying
an insertion of the gene trap vector pGT0lxf in intron 4
of the Gtf2ird1 gene (Gtf2ird1
(XS0608)Wtsi) (available from
t h eS a n g e rI n s t i t u t eG e n eT r a pR e s o u r c e )w a su s e dt o
generate mutant mice after injection into C57BL/6
blastocysts. The resulting chimeras were bred to CD1
females to produce Gtf2ird1
(XS0608)Wtsi mice that express a
GTF2IRD1-LacZ fusion protein under the control of the
endogenous Gtf2ird1 promoter. Mice were genotyped
using the primer mix: gtIRD1i4F 5'-CCCACCGACCTTA
TCTGAAC-3'; gtEn2i1R 5'-GGGTCTCTTTGTCA
GGGTCA-3'. The size of the amplicon is 466 bp for the
Gtf2ird1
(XS0608)Wtsi mutant allele.
X-gal staining of the Gtf2ird1
(XS0608)Wtsi mouse cortex
Male adult WT and Gtf2ird1
(XS0608)Wtsi mice were perfused
with PBS containing 2 mM MgCl2 (PBS+Mg) followed by
freshly made 2% PFA/0.2% glutaraldehyde in PBS+Mg.
W h o l eb r a i n sw e r ef r o z e ni ni s o p e n t a n eo nd r yi c ea n d5 0μm
coronal sections were cut on a cryostat. Free floating sections
were rinsed in PBS+Mg then fixed for 10 min in 2% PFA/
0.2%glutaraldehyde in PBS+Mg. Sections were rinsed in
PBS+Mg several times and immersed in LacZ staining
solution overnight containing: 5 mM Potassium ferricyanide,
5 mM potassium ferrocyanide, 0.01% sodium deoxycolate/
0.02% NP40, 1 mg/ml X-Gal in PBS+Mg. Sections were
washed with PBS+Mg, transferred to slides, counterstained
with Eosin Y, dehydrated, and mounted in Cytoseal. Sections
were viewed on a Leica DMRBE microscope (Leica Micro-
systems, Germany) using PL Fluotar 5X and 20X objectives.
Results
Serotonin elicits larger outward currents in layer V
pyramidal neurons in Gtf2ird1
−/− mice
The initial study was performed blind to genotype in a
group of 5 Gtf2ird1
−/− and 5 WT animals. In both groups,
bath application of 5-HT (30 µM, 30 s) induced prominent
inhibitory outward currents in voltage-clamp that were
repeatable on a second application after washout. In the
blind experiments, the mean outward current was signifi-
cantly larger in the Gtf2ird1
−/− mice (controls: 18±3.4 pA,
n=31; Gtf2ird1
−/− mice 38±6.4 pA, n=26; two-tailed
unpaired t test, P<0.05). Example recordings are shown
in Fig. 1 together with the mean 5-HT-elicited currents from
a larger dataset, which combines the blind recordings with
additional neurons recorded in brain slices from each
genotype for subsequent pharmacological experiments
(controls: 20 ± 2.8 pA, n=45; Gtf2ird1
−/− mice: 34±
4.7 pA, n=36; two-tailed unpaired t test, P<0.05). Of note,
the genotype difference in the modulatory effect of 5-HT
occurred in the absence of significant differences in the
membrane properties of the neurons: the average membrane
potential was −84±1 mV in controls and −83±2 mV in
Gtf2ird1
−/− mice; input resistance was 140±20 MΩ in
controls and 132±14 MΩ in Gtf2ird1
−/−;a n ds p i k e
amplitude was 77±3 mV in controls and 79±2 mV in
Gtf2ird1
−/− mice. Thus, despite similar baseline properties,
5-HT elicits a greater inhibitory outward current in layer V
output neurons of prefrontal cortex in Gtf2ird1
−/− mice than
in WT controls.
In both genotypes, the 5-HT-elicted outward currents
are direct and mediated by 5-HT1A receptors
We next examined whether the observed currents were
directly mediated by 5-HT receptors located on the
recorded cell. In order to answer this question, we applied
5-HT before and after blocking the voltage-gated sodium
channels necessary for action potential dependent neuro-
transmitter release with tetrodotoxin (TTX, 2 µM, 10 min).
The 5-HT-elicited outward currents were resistant to TTX,
with current amplitudes that were 99±14% (n=5) that of
currents recorded prior to TTX application in controls and
98±10% (n=4) in Gtf2ird1
−/− mice (Suppl. Figure 1).
Paired t tests revealed that responses were not significantly
different before and after TTX application in WT (P=NS)
or Gtf2ird1
−/− animals (P=NS). These results suggest that
the recorded responses are directly mediated by 5-HT
receptors on the layer V neurons.
Of the many subtypes of 5-HT receptors (Nichols and
Nichols 2008), the 5-HT1A receptor subtype is prominently
expressed in the prefrontal cortex where it mediates well-
documented inhibitory influences (Araneda and Andrade
1991; Béïque et al. 2004; Goodfellow et al. 2009). Further,
prior studies have highlighted the importance of this
receptor in prefrontal cortex for regulating anxiety
(Tauscher et al. 2001; Gross et al. 2002; Lanzenberger et
al. 2007). To test whether the observed 5-HT responses
were indeed mediated by the 5-HT1A receptor subtype, we
102 J Neurodevelop Disord (2010) 2:99–108applied the selective 5-HT1A antagonist WAY-100635
(30 nM, 10 min). As shown in Fig. 2, the responses to 5-
HT (30 µM, 30 s) after WAY-100635 (30 nM, 10 min) were
almost completely eliminated: 100±0% (n=4) suppression in
controls and 99±8% (n=7) suppression in Gtf2ird1
−/− mice.
In both genotypes, matched pair t-test statistics confirm a
significant current reduction in the presence of WAY-100635
(P<0.05). In layer V pyramidal cells of both controls and
Gtf2ird1
−/− animals, therefore, the recorded 5-HT responses
appear to be directly mediated by 5-HT1A receptors.
Serotonin 5-HT1A outward currents are unchanged
in prefrontal layer II/III
Since 5-HT has also been shown to exert inhibitory
influences on layer II/III cells of the medial prefrontal
cortex through 5-HT1A receptors (Goodfellow et al. 2009),
we examined whether these outward currents were en-
hanced the Gtf2ird1
−/− mice. However, the 5-HT responses
recorded in layer II/III cells were not significantly different
between Gtf2ird1
−/− and WT animals (Suppl. Figure 2).
Following bath application of 5-HT (30 µM, 30 s), the
average inhibitory current recorded in cells from WT
animals was 26±3.2 pA (n=12 cells) and 29±12 pA in
the Gtf2ird1
−/− (n=9 cells) (P=NS). Thus, 5-HT specifi-
cally elicits larger inhibitory responses in Gtf2ird1
−/− mice
in layer V and not in layer II/III.
Other inhibitory currents are not enhanced in layer V
of the Gtf2ird1
−/− mice
If the downstream effectors of 5-HT1A receptors are altered
in Gtf2ird1
−/− mice, then the currents elicited by other Gi/o-
coupled receptors might also be enhanced. We therefore
investigated the outward currents elicited by two other
inhibitory Gi/o-coupled receptors, the mGluR2/3 and
GABAB receptors, in layer V pyramidal neurons of the
Gtf2ird1
−/− mice. These neurons are known to also express
mGluR2/3 (Petralia et al. 1996; Melendez et al. 2004) and
GABAB receptors (Charles et al. 2003). The mGluR2/3
agonist t-APDC (30 µM, 30 s) and the GABAB agonist
baclofen (3 µM, 15 s) were bath applied and induced
outward currents similar to those elicited by 5-HT in layer
V pyramidal cells. As illustrated in Fig. 3, the responses to
both agonists were however not significantly different
between genotypes. The mGluR2/3 agonist t-APDC elicited
inhibitory outward currents of 21±6.0 pA in WT (n=6) and
24±7.0 pA in Gtf2ird1
−/− mice (n=4) (P=NS) while
baclofen induced currents of 55±5.8 pA in controls (n=6)
and 66±8.5 pA in Gtf2ird1
−/− (n=8) (P=NS). These data
suggest that altered receptor function in the Gtf2ird1
−/−
mice may be specific to 5-HT1A receptors since currents
elicited by two other Gi/o receptors in layer V pyramidal
neurons are not similarly affected.
Unchanged expression of 5-HT-related genes in frontal
cortex
We examined the expression of several 5-HT receptors and
the enzyme monoamine oxidase (MAO-A) in frontal cortex
of Gtf2ird1
−/− mice using quantitative real-time PCR. RNA
levels did not differ significantly between Gtf2ird1
−/− and
WT mice for any of the genes tested (Htr1a; Htr1b; Htr2a;
Htr2c; Maoa; unpaired t tests, P=NS, Table 1).
GTF2IRD1 protein expression is predominantly in layer V
of the frontal cortex
We used Gtf2ird1
(XS0608)Wtsi mice to examine GTF2IRD1
expression in the adult prefrontal cortex. In coronal sections
from a similar location to that used for the electrophysio-
logical recordings, there is obvious somatic expression of
the GTF2IRD1-LacZ fusion protein in many large neurons
Fig. 2 Serotonergic currents in layer V pyramidal neurons mediated
by 5-HT1A receptors in wildtype (WT) and Gtf2ird1
−/− mice. In
neurons from each genotype, (1.) the 5-HT-elicited outward currents
were suppressed by (2.) the selective antagonist of 5-HT1A receptors,
WAY-100635 (30 nM, 10 min). Gray bar indicates 5-HT application.
All the above traces were recorded after application of TTX (2 µM,
10 min), indicating that the 5-HT outward currents were mediated
directly by 5-HT1A receptors located on the recorded cells
J Neurodevelop Disord (2010) 2:99–108 103in layer V, as illustrated in Fig. 4. Layer V pyramidal
neurons are large and widely-spaced in contrast with the
smaller, more densely-packed neurons of layer II/III. Some
diffuse LacZ staining could also be seen in layer II/III, as
well as in layer I. It should be noted that the apical
dendrites of layer V pyramidal cells extend to the pial
surface and arborize extensively in layer II/III.
Discussion
In this study, we investigated how pyramidal cells in
prefrontal cortex are modulated by 5-HT in mice lacking
the general transcription factor gene Gtf2ird1. These
Gtf2ird1
−/− mice have previously been shown to exhibit a
low anxiety, low aggression and high sociability phenotype
(Young et al. 2008), which is reminiscent of symptoms seen
in individuals with WBS. We show that 5-HT elicits
enhanced outward currents in layer V pyramidal cells of
the prefrontal cortex via postsynaptic 5-HT1A receptors in
Gtf2ird1
−/− mice compared to their WT littermates. This
enhancement of an inhibitory current appears somewhat
layer and receptor specific. Consistent with the expression
pattern of GTF2IRD1 protein, serotonin 5-HT1A outward
currents are not enhanced in layer II/III pyramidal neu-
rons of Gtf2ird1
−/− mice. In addition, inhibitory currents
mediated by other Gi/o-coupled mGluR2/3 and GABAB
receptors in layer V pyramidal neurons are unchanged.
Together, our data raise important questions about the
mechanism that underlies the enhanced 5-HT1A currents in
layer V and the consequences of this current for prefrontal
functional connectivity in this mouse characterized by a
low anxiety phenotype.
Implications of elevated 5-HT1A currents for brain function
in a low anxiety mouse phenotype
Evidence suggests that elevated 5-HT1A receptor function
is inversely correlated with anxiety. In rodents, 5-HT1A
receptor knockout mice have been shown to exhibit higher
anxiety (Heisler et al. 1998; Parks et al. 1998;R a m b o ze t
al. 1998) while overexpression of 5-HT1A receptors leads
Table 1 Expression levels of 5-HT-related genes in the mouse frontal cortex
Expression Level Htr1a Htr1b Htr2a Htr2c Maoa
WT Gtf2ird1
−/− WT Gtf2ird1
−/− WT Gtf2ird1
−/− WT Gtf2ird1
−/− WT Gtf2ird1
−/−
Mean (n=12) 0.0590 0.0666 0.0957 0.0914 0.5541 0.6194 0.2478 0.2697 0.1649 0.1509
SD 0.0124 0.0187 0.0342 0.0332 0.1859 0.1030 0.0683 0.0273 0.0503 0.0166
SEM 0.0036 0.0054 0.0099 0.0096 0.0537 0.0297 0.0197 0.0079 0.0145 0.0048
95% CI 0.0070 0.0106 0.0193 0.0188 0.1052 0.0583 0.0386 0.0155 0.0285 0.0094
Fig. 3 Stimulation of two other
Gi/o-coupled receptors implicat-
ed in anxiety produces
similar responses in layer V
pyramidal neurons in both
wildtype (WT) and Gtf2ird1
−/−
mice. a The mGluR2/3 agonist
t-APDC (30 µM, 30 s) induces
similar responses in both
genotypes (WT: 21±6 pA;
Gtf2ird1
−/− mice: 24±7 pA;
P=NS). Gray bars denote
t-APDC application. b More-
over, the GABAB agonist
baclofen (3 µM, 15 s) elicits
similar responses in both
genotypes (WT: 55±6 pA;
Gtf2ird1
−/− mice: 66±9 pA;
P=NS). Gray bars indicate
baclofen application
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tory effects of 5-HT on layer V pyramidal neurons may
have profound effects on brain function since these cells
are considered the primary output neurons of the prefron-
tal cortex. They send projections to the amygdala,
hypothalamus, and striatum; in addition, they are the only
source of cortical feedback to several key neuromodula-
tory nuclei. For example, the dorsal raphe nucleus receives
its only cortical projection from layer V pyramidal cells of
the prefrontal cortex (Peyron et al. 1998;V e r t e s2004;
G a b b o t te ta l .2005; Gonçalves et al. 2009). Because these
cells provide 5-HT neurons of the raphe with negative
feedback (Hajós et al. 1998; Celada et al. 2001; Jankowski
and Sesack 2004), increased inhibition of layer V neurons
would disinhibit the raphe and thereby increase 5-HT
release in the prefrontal cortex. Previous HPLC findings in
the Gtf2ird1
−/− mice indicate that the levels of the 5-HT
metabolite 5-HIAA are significantly increased in the
prefrontal cortex and amygdala of Gtf2ird1 knockout mice
while 5-HT levels remain unchanged (Young et al. 2008).
Increases in the ratio of 5-HIAA to 5-HT are thought to
be an indicator of 5-HT turnover (Tozer et al. 1966).
Here, we report that levels of mRNA for MAO-A are not
significantly different in Gtf2ird1
−/− mice. Together, these
findings support the hypothesis that 5-HT release is
enhanced in the prefrontal cortex of these mice.
The prefrontal cortex also shares dense and reciprocal
connections with the amygdala (Ghashghaei and Barbas
2002; Gabbott et al. 2005). Interactions between the
prefrontal cortex and the amygdala are of great interest in
the investigation of neural mechanisms underlying the WBS
phenotype because of their role in anxiety and social
cognition. Neuroimaging studies have implicated the pre-
frontal cortex in anxiety both in healthy controls (Chua et al.
1999;L i o t t ie ta l .2000; Tillfors et al. 2001) and in subjects
with affective disorders (Osuch et al. 2000; Tillfors et al.
2001; Lanzenberger et al. 2007). Further, interactions of the
prefrontal cortex and amygdala have been shown to play a
critical role in social cognition (Morgan et al. 1993; Prather
et al. 2001;A m a r a l2002; Quirk et al. 2003). Recently, it has
been confirmed that prefrontal modulation of the amygdala is
dysregulated in WBS (Meyer-Lindenberg et al. 2005) but the
cellular mechanisms underlying this phenomenon remain to
be elucidated. We can posit in light of our findings that
greater inhibitory influences exerted by 5-HT on prefrontal
output cells may contribute to this functional uncoupling.
Possible mechanisms of altered 5-HT1A receptor function
in Gtf2ird1
−/− mice
There have been very few targets of the GTF2IRD1
transcription factor identified (O'Mahoney et al. 1998;
Fig. 4 The transcription factor
GTF2IRD1 is expressed in layer
V neurons of the prefrontal
cortex. Top, the blue rectangle
on the schematic depicts the
region of prefrontal cortex
shown in the images below.
Coronal sections of prefrontal
cortex from an adult
Gtf2ird1
(XS0608)Wtsi mouse (left)
and a control Gtf2ird1
+/+ mouse
(right) stained for LacZ activity.
WM denotes white matter, and
cortical layers are indicated in
roman numerals. Scale bar:
300 µm. Higher magnification
images illustrate the laminar
pattern of staining in medial
prefrontal cortex from the
regions shown above in black
rectangles. Note the somatic
expression of the GTF2IRD1-
LacZ fusion protein in layer V
neurons (examples shown with
arrowheads). Scale bar: 50 µm
J Neurodevelop Disord (2010) 2:99–108 105Polly et al. 2003; Jackson et al. 2005). While putative DNA
binding sequences have been found (Thompson et al. 2007;
Lazebnik et al. 2008; Palmer et al., 2010) none of the genes
evaluated in this study were determined to contain known
GTF2IRD1 binding sequences, consistent with the lack of
altered expression in the tested 5-HT receptors and MAO-A
genes. Since Gtf2ird1 is expressed widely during embryo-
genesis (Palmer et al. 2007), the elevated 5-HT1A currents
in layer Vof prefrontal cortex could be an indirect effect of
constitutively deleting this transcription factor. However,
our finding that GTF2IRD1-LacZ fusion protein is
expressed in layer V pyramidal neurons of the adult cortex
suggests that direct effects may also result from loss of
Gtf2ird1 transcriptional control.
The functional differences in 5-HT1A outward currents
we observed in layer V pyramidal neurons could arise at
several potential levels. We suggest that the enhanced
inhibitory currents observed in the Gtf2ird1
−/− mice do not
result from enhanced expression of the receptor since we
observed no difference in prefrontal 5-HT1A receptor
mRNA. The inhibitory actions of 5-HT1A receptors are
mainly mediated by increasing potassium conductance via
G-protein linked inwardly rectifying potassium (GIRK)
channel activation (Innis et al. 1988; Williams et al. 1988;
Penington et al. 1993). Since enhanced 5-HT1A-mediated
responses could be due to downstream changes from the 5-
HT1A receptor, such as its G-protein linked potassium
channel activation, we investigated the currents mediated
by two other inhibitory Gi/o-coupled receptors, the group II
metabotropic glutamate (mGluR2/3) and GABAB receptors.
Because these receptors are also linked to G-protein
activated potassium channels (Andrade et al. 1986; Innis
et al. 1988), we postulated that if responses mediated by
these receptors were also enhanced, altered function of
downstream effectors shared by all three receptors was
likely at play in mediating these larger currents. This,
however, was not the case, suggesting that the mechanisms
underlying increased 5-HT1A-mediated inhibitory responses
are receptor specific.
In this regard, aberrant 5-HT1A receptor function could
arise from altered sensitivity to the systemic stress response.
The hypothalamic-pituitary-adrenal (HPA) axis plays a
crucial role in mediating anxiety behaviors and has been
shown to interact with the serotonergic neuromodulatory
system (Lanfumey et al. 2008). Exposure to stressors leads to
the release of corticosteroids from the adrenal gland in
response to hormonal signals from the hypothalamus and
pituitary gland. Interestingly, chronic corticosteroid exposure
has been shown to significantly reduce 5-HT1A-mediated
inhibitory currents in the brain whereas adrenalectomy has
the opposite effect. Furthermore, it has been suggested that
this modulation of postsynatptic 5-HT1A function by cortico-
steroids can be mediated at the level of G protein coupling
(Okuhara and Beck 1998). In light of this prior study, we can
speculate that the low anxiety Gtf2ird1
−/− mice may be
exposed to less circulating corticosteroids or that they could
be less sensitive to these hormones. The integrity of the HPA
axis in these mice is a critical subject for future study.
Relevance of the Gtf2ird1
−/− mouse model to WBS
Individuals with WBS have been said tobe gregarious, overly
friendly and to possess a heightened interest in other people
(Bellugi et al. 1999; Jones et al. 2000; Doyle et al. 2004). In
this respect, the finding that Gtf2ird1
−/− mice exhibit low
anxiety and increased interest in other mice proves to be
highly valuable, especially in light of the fact that prior to the
characterization of this mouse, no other mouse model
exhibited behaviors akin to the hypersociability seen in
WBS (Young et al. 2008). The caveat is, however, that
Gtf2ird1
−/− mice exhibit decreased anxiety on tasks of both
social and non-social nature, as on the resident intruder test
and elevated plus maze task, respectively. This stands in
contrast to individuals with WBS, who despite their low
social anxiety tend to display a high degree of non-social
anxiety. Indeed, approximately half of patients have specific
phobias (Dykens 2003;L e y f e re ta l .2006). It has not been
examined, however, whether the Gtf2ird1
−/− mice may show
enhanced anxiety under certain conditioning paradigms
despite their seemingly low innate anxiety.
Interestingly, anecdotal evidence suggests that people
with WBS are hypersensitive to the most commonly
prescribed treatment for non-social anxiety, the selective
serotonin reuptake inhibitors (SSRIs) (Cherniske et al.
2004; Pober 2006). Standard doses of these medicines are
associated with adverse effects such as further disinhibition
(Cherniske et al. 2004). Chronic administration of such
medicines is well-known to downregulate 5-HT1A autor-
eceptors within the dorsal raphe, but has only recently been
shown to have the opposite effect, a pronounced enhance-
ment, on the function of prefrontal 5-HT1A receptors
(Moulin-Sallanon et al. 2009). Our results give insight into
a prefrontal cellular mechanism that would contribute to the
hypersensitivity of individuals with WBS to SSRIs.
Conclusions
The Gtf2ird1
−/− mouse model allows us to study how the
deletion of one of the genes in the WBS critical region on
chromosome 7 can alter neurophysiology and lead to the
enhancement of inhibitory 5-HT currents in the main output
neurons of the prefrontal cortex. As such, this model can help
guide future pharmacological and functional human imaging
studies in WBS and provide insight into alternative thera-
peutic targets to help restore normal prefrontal excitability.
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